about
Gene expression profiles stratified according to type 1 diabetes mellitus susceptibility regions.Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.Association of Interferon-gamma gene polymorphism (+874 T/A) with systemic sclerosis.BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas.Interleukin-17A expression in patients presenting with nasal polyposis.HLA polymorphisms as incidence factor in the progression to end-stage renal disease in Brazilian patients awaiting kidney transplant.Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.Overexpression of immunomodulatory mediators in oral precancerous lesions.HLA-G expression in the skin of patients with systemic sclerosis.The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinoma.TNFa-e Microsatellite, HLA-DRB1 and -DQB1 Alleles and Haplotypes in Brazilian Patients Presenting Recently Diagnosed Type 1 Diabetes MellitusPatients with Systemic Sclerosis Present Increased DNA Damage Differentially Associated with DNA Repair Gene PolymorphismsInterferon-γ +874 Polymorphism in the First Intron of the Human Interferon-γ Gene and Kidney Allograft OutcomeExtensive genetic polymorphism in the haplotype STR-TNF and HLA class I with the onset and evolution of psoriasis vulgarisFrequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcomeAssociation between the HLA-G molecule and lymph node metastasis in papillary thyroid cancerRelevance of HLA-G, HLA-E and IL-10 expression in lip carcinogenesisAnalysis of the BRAF V600E mutation in primary cutaneous melanomaAnalysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinomaAnalysis of HLA-G protein expression in leprosy
P50
Q33397070-03CA334A-6BC1-40DA-8D3E-FD13D39B721DQ36582874-0A78D12D-7EB3-41FD-913C-9964097344D7Q37327119-1F5819D6-9C4C-4EF8-9F5D-13912608829FQ38959781-772E042B-0398-465D-867A-69C823C32E30Q43422656-E33ECC87-6BEB-4628-A7FC-1144EDCE1719Q46454641-FEBA2EA3-B634-4CCC-9F95-4A567C76D81FQ46834069-E221208C-20B0-4DEA-A34E-2B6B38AD507AQ47754735-FD23A542-2E85-4748-BF59-465F260B2D05Q48001869-AA8FADC2-1007-4406-9202-EF02ECB5E756Q53079270-2A28BA0D-C3AC-4507-B2AF-0676E9C9463CQ58286311-BDC73396-C2EF-4DFD-92CF-67A6ACB3B17CQ58851109-77F36F2D-29E8-4EDB-B641-DDFCA380A281Q58851207-BEAD5E69-43A2-40E4-BB84-4CD111E1EF1CQ58851230-438B6EA2-1E6B-47FE-90E1-0566608C1C9FQ58851261-510AAD22-11EA-4488-88F6-77F9486BA691Q85768328-217FED59-CFD8-4655-A7CB-4F124C32941DQ87002725-26B05D42-028A-4E49-93E5-03A7AC9AF499Q87308395-DB514FC5-57B3-4AD0-81E6-5075EC9444F3Q87740167-FCA8E098-D02A-4545-A9E8-A509B0313C25Q96580730-A44A3B08-AD70-44F9-AC7D-609C3A0100E8
P50
description
researcher ORCID ID = 0000-0001-5441-4186
@en
wetenschapper
@nl
name
Isabela J Wastowski
@ast
Isabela J Wastowski
@en
Isabela J Wastowski
@es
Isabela J Wastowski
@nl
type
label
Isabela J Wastowski
@ast
Isabela J Wastowski
@en
Isabela J Wastowski
@es
Isabela J Wastowski
@nl
prefLabel
Isabela J Wastowski
@ast
Isabela J Wastowski
@en
Isabela J Wastowski
@es
Isabela J Wastowski
@nl
P106
P21
P31
P496
0000-0001-5441-4186